UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 49

Sortiert nach

Direct-acting antiviral agents for hepatitis C: structural and mechanistic insights

Nature reviews. Gastroenterology & hepatology, 2016-06, Vol.13 (6), p.338

2016

Link zum Volltext

Verfügbarkeit prüfen

Second generation direct-acting antivirals – Do we expect major improvements?

Journal of hepatology, 2016-10, Vol.65 (1), p.S130-S142

2016

Link zum Volltext

Verfügbarkeit prüfen

Direct-Acting Antivirals for Hepatitis C Virus (HCV): The Progress Continues

Current drug targets, 2017-01, Vol.18 (7), p.851

Feld, Jordan J

2017

Link zum Volltext

Verfügbarkeit prüfen

Ribavirin revisited in the era of direct‐acting antiviral therapy for hepatitis C virus infection

Liver international, 2017-01, Vol.37 (1), p.5-18

2017

Link zum Volltext

Verfügbarkeit prüfen

Early Changes in Natural Killer Cell Function Indicate Virologic Response to Interferon Therapy for Hepatitis C

Gastroenterology (New York, N.Y. 1943), 2011-10, Vol.141 (4), p.1231-1239.e2

2011

Link zum Volltext

Verfügbarkeit prüfen

What Is Needed to Move Toward Single-Step Diagnosis of Current HCV Infection?

The Journal of infectious diseases, 2024-05, Vol.229 (Supplement_3), p.S316-S321

Feld, Jordan J

2024

Link zum Volltext

Verfügbarkeit prüfen

Race or genetic makeup for hepatitis C virus treatment decisions?

Hepatology (Baltimore, Md.), 2017-06, Vol.65 (6), p.2124-2125

2017

Link zum Volltext

Verfügbarkeit prüfen

An update on the management of chronic hepatitis C: 2015 Consensus guidelines from the Canadian Association for the Study of the Liver

Canadian journal of gastroenterology & hepatology, 2015-01, Vol.29 (1), p.19-34

2015

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis C virus infection characteristics and treatment outcomes in Canadian immigrants

BMC public health, 2020-09, Vol.20 (1), p.1345-1345, Article 1345

2020

Link zum Volltext

Verfügbarkeit prüfen

HCV elimination: It will take a village and then some

Journal of hepatology, 2020-04, Vol.72 (4), p.601-603

Feld, Jordan J.

2020

Link zum Volltext

Verfügbarkeit prüfen

Role of HVR1 sequence similarity in the cross-genotypic neutralization of HCV

Virology journal, 2020-09, Vol.17 (1), p.140-140, Article 140

2020

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis C point-of-care diagnostics: in search of a single visit diagnosis

Expert review of molecular diagnostics, 2017-12, Vol.17 (12), p.1109-1115

2017

Link zum Volltext

Verfügbarkeit prüfen

Treatment indication and response to standard of care with peginterferon and ribavirin in acute and chronic HCV infection

Baillière's best practice & research. Clinical gastroenterology, 2012-08, Vol.26 (4), p.429-444

Feld, Jordan J., MD, MPH

2012

Link zum Volltext

Verfügbarkeit prüfen

Interferon-free strategies with a nucleoside/nucleotide analogue

Seminars in liver disease, 2014-02, Vol.34 (1), p.37

Feld, Jordan J

2014

Link zum Volltext

Verfügbarkeit prüfen

Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin

The New England journal of medicine, 2014-04, Vol.370 (17), p.1594-1603

2014

Link zum Volltext

Verfügbarkeit prüfen

Defective Hepatic Response to Interferon and Activation of Suppressor of Cytokine Signaling 3 in Chronic Hepatitis C

Gastroenterology (New York, N.Y. 1943), 2007-02, Vol.132 (2), p.733-744

2007

Link zum Volltext

Verfügbarkeit prüfen

Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: An integrated safety and efficacy analysis

Hepatology (Baltimore, Md.), 2015-07, Vol.62 (1), p.79-86

2015

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Sofosbuvir/Velpatasvir in Patients With Chronic Hepatitis C Virus Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ASTRAL Trials

Clinical infectious diseases, 2016-12, Vol.63 (11), p.1479-1481

2016

Link zum Volltext

Verfügbarkeit prüfen

No scientific basis to restrict 8 weeks of treatment with ledipasvir/sofosbuvir to patients with hepatitis C virus RNA <6,000,000 IU/mL

Hepatology (Baltimore, Md.), 2016-01, Vol.63 (1), p.28-30

2016

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Hepatitis C Screening and Treatment Among Psychiatry Inpatients

The journal of clinical psychiatry, 2023-07, Vol.84 (5)

2023

Link zum Volltext

Verfügbarkeit prüfen

We have reached single-visit testing, diagnosis, and treatment for hepatitis C infection, now what?

Expert review of molecular diagnostics, 2024-03, Vol.24 (3), p.177-15

2024

Link zum Volltext

Verfügbarkeit prüfen

Outcomes of early vs late treatment initiation in solid organ transplantation from hepatitis C virus nucleic acid test-positive donors to hepatitis C virus-uninfected recipients: Results from the HCV-TARGET study

American journal of transplantation, 2024-03, Vol.24 (3), p.468-478

2024

Link zum Volltext

Verfügbarkeit prüfen

A bivalent HCV peptide vaccine elicits pan-genotypic neutralizing antibodies in mice

Vaccine, 2020-10, Vol.38 (44), p.6864-6867

2020

Link zum Volltext

Verfügbarkeit prüfen

The health impact of delaying direct‐acting antiviral treatment for chronic hepatitis C: A decision‐analytic approach

Liver international, 2020-01, Vol.40 (1), p.51-59

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 49

Suche als RSS-Feed

Aktive Filter

SpracheSpanisch

ThemaHepacivirus - Genetics

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(49)

Sprache

Englisch
(49)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Humans
(48)
Science & Technology
(46)
Life Sciences & Biomedicine
(45)
Antiviral Agents - Therapeutic Use
(31)
Hepatitis C, Chronic - Drug Therapy
(31)
Female
(27)
Genotype
(27)
Male
(27)
Gastroenterology & Hepatology
(24)
Hepatitis C
(23)
Adult
(22)
Hepatitis C, Chronic - Virology
(22)
Middle Aged
(21)
Drug Therapy, Combination
(17)
Hepatitis
(17)
Antiviral Agents - Adverse Effects
(15)
Aged
(14)
Treatment Outcome
(14)
Hepatitis C - Drug Therapy
(13)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Direct-acting antiviral agents for hepatitis C: structural and mechanistic insights

Second generation direct-acting antivirals – Do we expect major improvements?

Direct-Acting Antivirals for Hepatitis C Virus (HCV): The Progress Continues

Ribavirin revisited in the era of direct‐acting antiviral therapy for hepatitis C virus infection

Early Changes in Natural Killer Cell Function Indicate Virologic Response to Interferon Therapy for Hepatitis C

What Is Needed to Move Toward Single-Step Diagnosis of Current HCV Infection?

Race or genetic makeup for hepatitis C virus treatment decisions?

An update on the management of chronic hepatitis C: 2015 Consensus guidelines from the Canadian Association for the Study of the Liver

Hepatitis C virus infection characteristics and treatment outcomes in Canadian immigrants

HCV elimination: It will take a village and then some

Role of HVR1 sequence similarity in the cross-genotypic neutralization of HCV

Hepatitis C point-of-care diagnostics: in search of a single visit diagnosis

Treatment indication and response to standard of care with peginterferon and ribavirin in acute and chronic HCV infection

Interferon-free strategies with a nucleoside/nucleotide analogue

Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin

Defective Hepatic Response to Interferon and Activation of Suppressor of Cytokine Signaling 3 in Chronic Hepatitis C

Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: An integrated safety and efficacy analysis

Efficacy and Safety of Sofosbuvir/Velpatasvir in Patients With Chronic Hepatitis C Virus Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ASTRAL Trials

No scientific basis to restrict 8 weeks of treatment with ledipasvir/sofosbuvir to patients with hepatitis C virus RNA <6,000,000 IU/mL

Evaluation of Hepatitis C Screening and Treatment Among Psychiatry Inpatients

Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial

We have reached single-visit testing, diagnosis, and treatment for hepatitis C infection, now what?

Outcomes of early vs late treatment initiation in solid organ transplantation from hepatitis C virus nucleic acid test-positive donors to hepatitis C virus-uninfected recipients: Results from the HCV-TARGET study

A bivalent HCV peptide vaccine elicits pan-genotypic neutralizing antibodies in mice

The health impact of delaying direct‐acting antiviral treatment for chronic hepatitis C: A decision‐analytic approach

Aktive Filter

Suchergebnisse filtern